Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in severe asthma
NCT01841281Phase 2Completed
- Start
- Aug 2013
- Primary completion
- Aug 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of arginine in asthma. Primary endpoint: Number of Acute Exacerbations at 3 months. Started Aug 2013; status: completed.
02
Drugs
arginine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01841281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841281.